AMBP Price Prediction Next Week
Analysis and Insights
Technical Analysis:
Ardagh Metal Packaging (AMBP) is currently trading at $2.90, with key technical indicators suggesting a neutral to slightly bullish outlook. The Relative Strength Index (RSI) at 53.08 indicates the stock is not overbought or oversold, while the MACD at 0.04 shows a slight upward momentum.
Fibonacci Levels:
The Fibonacci levels suggest a pivot point at $2.85, with resistance levels at $3.00 and $3.09. The stock is currently trading near the lower end of its recent range, with potential upside to the first resistance level.
{FIBONACCI:symbol=AMBP.N, type=0}
Analyst Sentiment:
Analysts have a Hold rating on AMBP, with an average price target of $3.60, representing a 24.14% upside from current levels. RBC Capital and Morgan Stanley have maintained Hold ratings, with price targets of $4.00 and $3.20, respectively.
Price Prediction:
Based on the technical indicators and analyst sentiment, AMBP is expected to trade between $2.80 and $3.20 next week. The stock is likely to test the $3.10 level, with a potential high of $3.20 if it breaks above resistance.
Recommendation:
Buy Ardagh Metal Packaging (AMBP) at the current price of $2.90, with a target price of $3.10. Set a stop-loss at $2.80 to manage risk.
AMBP Similar Chart Price Prediction
The price of AMBP is predicted to go up 0.98%, based on the high correlation periods with GHI. The similarity of these two price pattern on the periods is 93.59%.
AMBP
GHI
Up: 0.98%Similarity: 93.59%
AMBP Revenue Forecast
AMBP EPS Forecast
AMBP FAQs
What is AMBP revenue forecast for next quarter？
What is AMBP eps forecast for next quarter？
AMBP Analyst's Forecast
Gabe Hajde
Wells Fargo
Buy → Hold
2025-01-16
Price Target
$3.6 → $3.35
Upside
+20.72%
Wells Fargo downgraded Ardagh Metal Packaging to Equal Weight from Overweight with a price target of $3.35, down from $3.60. The firm believes beverage can manufacturers face the most significant headwinds within its coverage to start 2025, driven by an "already challenging" macro backdrop, trade policy risks, the "Make America Healthy Again" agenda, and the Surgeon General's warning on alcohol. For Ardagh, Wells' concerns are excess capacity, high leverage, and a "punitive" dividend paid to its largest shareholder that limits free cash flow.
Pamela Kaufman
Morgan Stanley
Sell → Hold
2025-01-13
Price Target
$3.6 → $3.1
Upside
+9.35%
Curt Woodworth
UBS
Hold
2025-01-10
Price Target
$4.25 → $2.75
Downside
-3%
